BACKGROUND Primary mediastinal diffuse large B cell lymphoma (DLBCL) presenting as a large intracardiac tumor is extremely rare and has not been significantly reported in the literature. Cardiac lymphoma consists of 2 subtypes: mediastinal DLBCL invading the heart and primary cardiac lymphoma. Both subtypes have a poor prognosis and are treated similarly. Mediastinal DLBCL is a life-threatening condition that, if diagnosed early, has a better survival rate. This is a rare case of a mediastinal DLBCL invading the right atrium as a large intracardiac mass, causing partial obstruction of the tricuspid valve without hemodynamic compromise. CASE REPORT A 57-year-old female presented with unintentional weight loss, fatigue, exertional dyspnea, and cough for 8 weeks. Transesophageal echocardiogram showed a mass (3.5×3.5 cm) in the posterior wall of the right atrium partially obstructing the tricuspid valve. Biopsy revealed DLBCL. Given new-onset lymphoma, a human immunodeficiency virus (HIV) test was done and came back positive. CD4 count was 100 cells/mm³. Chemotherapy was initiated with rituximab, cyclophosphamide, epirubicin, vincristine, and prednisone (R-CHOP). Highly active anti-retroviral (HAART) therapy was started for HIV. After treatment with R-CHOP and HAART, the patient had complete resolution of the mass and symptoms on follow-up imaging and evaluation at 6 months. CONCLUSIONS Mediastinal DLBCL invading the heart is a life-threatening form of non-Hodgkin's lymphoma (NHL) and early diagnosis and treatment is critical as prognosis is poor especially if diagnosed in later stages of the disease. Testing for HIV is important as 5% of HIV patients are susceptible to developing NHL.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913268PMC
http://dx.doi.org/10.12659/AJCR.917159DOI Listing

Publication Analysis

Top Keywords

mediastinal dlbcl
16
dlbcl invading
12
rare case
8
diffuse large
8
large cell
8
cell lymphoma
8
large intracardiac
8
cardiac lymphoma
8
invading heart
8
tricuspid valve
8

Similar Publications

Article Synopsis
  • * A 78-year-old male with dysphagia underwent several diagnostic procedures, ultimately confirming a diagnosis of diffuse large B-cell lymphoma (DLBCL) after various initial findings were misattributed to less severe conditions.
  • * The rapid progression of the disease in this patient underscored the need for prompt recognition of primary oesophageal lymphoma, especially in older individuals, and ultimately shifted the focus to palliative care due to the aggressive nature of the illness.
View Article and Find Full Text PDF

BACKGROUND Cardiac tumors are divided into 2 categories: primary, originating from the heart, and metastatic, which spread to the heart from a different location, with metastatic tumors representing the vast majority. Cardiac tumors, depending on the size and location, can predispose patients to arrhythmic or hemodynamic complications. We present a patient with a history of B-cell lymphoma (DLBCL) in remission for 3 years who developed acute onset congestive heart failure and complete heart block secondary to DLBCL invasion of the myocardium.

View Article and Find Full Text PDF
Article Synopsis
  • Combination antiretroviral therapy (ART) has significantly improved the treatment outcomes for patients with HIV-associated non-Hodgkin lymphoma, specifically Burkitt lymphoma and diffuse large B-cell lymphoma, based on a study of 127 patients treated over 17 years.
  • The study found that DA-EPOCH ± R was the most common therapy for HIV-BL, while CHOP± R was used for HIV-DLBCL, with complete response rates of 36% and 44%, respectively.
  • Despite these advancements, challenges remain in treating HIV-related lymphomas in China due to low rates of pre-diagnosis ART, high patient morbidity, and late-stage diagnoses.
View Article and Find Full Text PDF

High expression of RHOF is an effective diagnostic marker and a potential prognostic indicator for primary mediastinal large B-cell lymphoma.

Virchows Arch

December 2024

Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

Article Synopsis
  • - The study investigates the challenges in diagnosing primary mediastinal large B-cell lymphoma (PMBL) due to its similarities with other lymphomas and low incidence, using data from 51 PMBL cases and 375 diffuse large B-cell lymphoma (DLBCL-NOS) instances.
  • - Results show that RHOF expression is significantly higher in PMBL compared to DLBCL-NOS, indicating that RHOF is a better diagnostic marker than traditional markers like CD23 and CD30, with ROC curve analysis supporting its usefulness.
  • - High levels of RHOF are also linked to poorer overall and progression-free survival in PMBL patients, suggesting that RHOF has potential for improving diagnosis and prognosis in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • Primary pulmonary lymphoma (PPL) is a rare lung condition where lymphoid cells grow abnormally, leading to symptoms like cough, fever, and shortness of breath; it can often be misdiagnosed as tuberculosis due to overlapping symptoms.
  • Accurate diagnosis of PPL is critical and typically requires small biopsies for histopathological analysis, guiding treatment options such as chemotherapy and immunotherapy.
  • The text presents a case of a patient initially thought to have tuberculosis but diagnosed with PPL through thorough evaluations, including a thoracoscopy-guided biopsy, emphasizing the importance of a multidisciplinary approach for effective diagnosis and management.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!